Association of TNFAIP3 With Immune-mediated TTP

NAActive, not recruitingINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

April 4, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Thrombotic Thrombocytopenic Purpura, Acquired

Interventions

PROCEDURE

blood sampling

Blood sampling for experimental analyses.

Trial Locations (1)

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan

All Listed Sponsors

lead

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

OTHER